SNCA and Parkinson disease: Overexpression of human WT α-synuclein or PD-associated mutants, such as A53T, A30P, S129A, and S129D α-synuclein, have triggered characteristics associated with PD, including dopamine neuron loss, reduced dopamine content, motor impairments, and neuroinflammation [179].